Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cost of antiretroviral drug resistance in HIV-positive patients.

Antiviral therapy - 1 Jan 2014

Krentz Hartmut B, Ko Karen, Beckthold Brenda, Gill M John

Abstract excerpt

INTRODUCTION: Antiretroviral (ARV) drug resistance limits treatment choices, often necessitating the selection of drugs with less desirable pill burdens, toxicity profiles, drug interactions and dosing schedules, and may increase cost. We examine the impact of resistance on the cost of HIV care. METHODS: All adult HIV-positive individuals newly referred for HIV care from 1 January 2007 to 1 January 2011 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alberta
Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Drug Resistance, Viral

Share to Health Care Costs

Share to HIV Infections

Source

Identifiers

PMID: 24296618
DOI: 10.3851/IMP2709

Genes

GART

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cost of antiretroviral drug resistance in HIV-positive patients.PMID 24296618Read ↗

The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected PatientsSemantic proximity Read ↗

Reporting on the prevalence of antiretroviral drug resistance in a regional HIV population over 20 years: a word of caution.Semantic proximity Read ↗

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness.Semantic proximity Read ↗

Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.Semantic proximity Read ↗

Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income SettingsSemantic proximity Read ↗

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.Semantic proximity Read ↗

Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART).Semantic proximity Read ↗

Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysisSemantic proximity Read ↗

Cost-effectiveness analysis of using antiretroviral drug resistance testing.Semantic proximity Read ↗

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.Semantic proximity Read ↗

The effect of transmitted HIV-1 drug resistance on pre-therapy viral load.Semantic proximity Read ↗

Rates of transmission of antiretroviral drug resistant strains of HIV-1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.